SCHEMBL2463071

SCHEMBL2463071

CS([N])(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethyl Sulfone SCHEMBL169867 0.72 KDM4E (1.00)
Dimethyl Sulfone SCHEMBL19382 0.72
SCHEMBL3955516 0.71
SCHEMBL26983768 0.67
SCHEMBL136797 0.67
Nitrogen SCHEMBL5381692 0.67
SCHEMBL97574 0.67
SCHEMBL25600 0.67
SCHEMBL10725151 0.67
SCHEMBL6280813 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113286792-B N-chromen-4-one containing derivatives for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-12-05 CN claimed
CN-116969923-A Heteroaryl amino compounds, methods of preparation and use thereof 北京鞍石生物科技有限责任公司 2023-10-31 CN claimed
US-20230229077-A1 PHOTOACID GENERATOR FOR CHEMICALLY AMPLIFIED PHOTORESISTS FOR DEEP ULTRAVIOLET AND EXTREME ULTRAVIOLET LITHOGRAPHY INTERNATIONAL BUSINESS MACHINES CORPORATION 2023-07-20 US claimed
CN-113286792-A N-containing chromen-4-one derivatives for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2021-08-20 CN claimed
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP claimed
US-5707989-A ANTITUMOR AGENTS, INHIBITING SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES DR. KARL THOMAE GMBH (DE) 1998-01-13 US claimed
EP-0503548-B1 Cyclic urea derivatives, medicaments contaning them and process for their preparation THOMAE GMBH DR K (DE) 1997-06-04 EP claimed
US-4570000-A HISTAMINE HH-2 ANTAGONISTS; GASTROINTESTINAL DISORDERS IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1986-02-11 US claimed
CN-111433203-B Enantiomer of substituted thiazoles as antiviral compounds 创新分子股份有限公司 2024-02-13 CN disclosed
CN-113286792-B N-chromen-4-one containing derivatives for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-12-05 CN disclosed
CN-116969923-A Heteroaryl amino compounds, methods of preparation and use thereof 北京鞍石生物科技有限责任公司 2023-10-31 CN disclosed
US-20230229077-A1 PHOTOACID GENERATOR FOR CHEMICALLY AMPLIFIED PHOTORESISTS FOR DEEP ULTRAVIOLET AND EXTREME ULTRAVIOLET LITHOGRAPHY INTERNATIONAL BUSINESS MACHINES CORPORATION 2023-07-20 US disclosed
CN-111601799-B Fused imidazole derivatives as Il-17 modulators UCB生物制药有限责任公司 2023-06-09 CN disclosed
CN-109071473-B Antiviral compounds 创新分子股份有限公司 2022-12-09 CN disclosed
US-4649149-A ANTHELMINTICS CIBA-GEIGY CORPORATION (US) 1987-03-10 US disclosed
US-4570000-A HISTAMINE HH-2 ANTAGONISTS; GASTROINTESTINAL DISORDERS IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1986-02-11 US disclosed
US-4511567-A ANTHELMINTICS CIBA-GEIGY CORPORATION (US) 1985-04-16 US disclosed
US-4460584-A GUANIDINE DERIVATIVES, ANTISECRETORY AGENT IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-07-17 US disclosed
EP-0060696-A1 Nitrogen heterocycles IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-22 EP disclosed
EP-0041046-A1 Benzazol derivatives, processes for their preparation, their pharmaceutical composition and their application CIBA-GEIGY AG (CH) 1981-12-02 EP disclosed